Share Your Research, Maximize Your Social Impacts
Unusual Cutaneous Toxicity After Prolonged Use Of Hydroxyurea In Polycythemia Vera: A Case Report
Journal: Journal of Hematology and Oncology Research (Vol.1, No. 3)Publication Date: 2015-01-23
Authors : Elisa Molinari; Gianfranco Barabino; Eleonora Arboscello; Lisette Del Corso; Andrea Bellodi; Vera Sicbaldi; Serena Favorini; Riccardo Ghio; Enrico Balleari;
Page : 10-14
Keywords : Hydroxyurea; Polycythemia vera; myeloproliferative neoplasms; mucocutaneous toxicity;
Source : Download
Find it from : Google Scholar
Abstract
Hydroxyurea (HU) is commonly used for the long-term treatment of patients with chronic myeloproliferative neoplasms. The drug is usually well tolerated in the large majority of subjects, although systemic and/or localized toxicities have seldom been reported. Here we report a case of unusual cutaneous toxicity due long-term use of HU in a patient with polycythemia vera.
Other Latest Articles
- Acquired Abnormalities Of Plasma Von Willebrand Factor Related Parameters And ADAMTS13 Autoantibodies In Aggressive Haematological Malignancies
- Investigating The Relationship Between Children, Depression, And Pain In Black Women With Sickle Cell Disease (SCD)
- Identification Of Novel Biomarker For Human Uterine Leiomyosarcoma
- Diagnostics Of Progressive Multifocal Leukoencephalopathy In A Patient With Concomitant Lymphoma Infiltration Of Central Nervous System During R-CHOP Chemotherapy- A Case Presentation And Review Of The Literature
- MicroRNAs: As A Novel Potential Tool For Diagnosis, Prognosis, And Therapeutic Agents In Hypertension
Last modified: 2015-12-12 00:37:35